Lymphocyte deficiencies increase susceptibility to friend virus-induced erythroleukemia in Fv-2 genetically resistant mice

Journal of Virology

Volumn 73, Issue 8, 1999, Pages 6468-6473

  Hasenkrug, Kim J ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; DISEASE PREDISPOSITION; ERYTHROLEUKEMIA; FRIEND LEUKEMIA VIRUS; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MITOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; VIRUS INDUCTION; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS RESISTANCE;

EID: 0032798210     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.8.6468-6473.1999     Document Type: Article

References (54)

1. Behringer, R. R., and M. J. Dewey. 1985. Cellular site and mode of Fv-Z gene action. Cell 40:441-447.
2. Ben-David, Y., and A. Bernstein. 1991. Friend virus-induced erythroleukeroia and the multistage nature of cancer. Cell 64:831-834.
3. Britt, W. J., and B. Chesebro. 1983. Use of monoclonal anti-gp70 antibodies to mimic the effects of the Rfv-3 gene in mice with Friend virus-induced leukemia. J. Immunol. 130:2363-2367.
4. Chesebro, B., M. Miyazawa, and W. J. Britt 1990. Host genetic control of spontaneous and induced immunity to Friend murine retrovirus infection. Annu. Rev. Immunol. 8:477-499.
5. Chesebro, B., and K. Wehrly. 1979. Identification of a non-H-2 gene (Rfv-3) influencing recovery from viremia and leukemia induced by Friend virus complex. Proc. Natl. Acad. Sci. USA 76:425-429.
6. Chesebro, B., and K. Wehriy. 1978. Rfv-1 and Rfv-2, two H-2-associated genes that influence recovery from Friend leukemia virus-induced splenomegaly. J. Immunol. 120:1081-1085.
7. Cobbold, S. P., A. Jayasuriya, A. Nash, T. D. Prospero, and H. Waldmann. 1984. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature (London) 312:548-551.
8. Corbin, A., and M. Sitbon. 1993. Protection against retroviral diseases after vaccination is conferred by interference to superinfection with attenuated murine viruses. J. Virol. 65:2539-2544.
9. Dittmer, U., D. M. Brooks, and K. J. Hasenkrug. 1998. Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms. J. Virol. 72:6554-6558.
10. Doig, D., and B. Chesebro. 1979. Anti-Friend virus antibody is associated with recovery from viremia and loss of viral leukemia cell surface antigens in leukemic mice: Identification of Rfv-3 as a gene locus influencing antibody production. J. Exp. Med. 150:10-19.
11. Earl, P. L., B. Moss, R. P. Morrison, K. Wehrly, J. Nishio, and B. Chesebro. 1986. T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant. Science 234:728-731.
12. Ferro, F. E., Jr., S. L. Kozak, M. E. Hoatlin, and D. Rabat. 1993. Cell surface site for mitogenic interaction of erythropoietin receptors with the membrane glycoprotein encoded by Friend erythroleukemia virus. J. Biol. Chem. 268: 5741-5747.
13. Geib, R. W., M. Dizik, R. Anand, and F. Lilly. 1987. Infection and transformation of Fv-2rr erythroprogenitor cells with Friend virus. Virus Res. 8:327-333.
14. Hasenkrug, K. J., D. M. Brooks, M. N. Robertson, R. V. Srinivas, and B. Chesebro. 1998. Immunoprotective determinants in Friend murine leukemia virus envelope protein. Virology 248:66-73.
15. Hasenkrug, K. J., D. M. Brooks, and B. Chesebro. 1995. Passive immunotherapy for retroviral disease: influence of major histocompatibility complex type and T-cell responsiveness. Proc. Natl. Acad. Sci. USA 92:10492-10495.
16. + T cells in controlling retrovirus replication and spread in persistently infected mice. J. Virol. 72:6559-6564.
17. Hasenkrug, K. J., D. M. Brooks, J. Nishio, and B. Chesebro. 1996. Differing T-cell requirements for recombinant retrovirus vaccines. J. Virol. 70:368-372.
18. Hoatlin, M. E., and D. Kabat. 1995. Host-range control of a retroviral disease: Friend erythroleukemia. Trends Microbiol. 3:51-57.
19. Hoatlin, M. E., S. L. Kozak, F. Lilly, A. Chakraborti, C. A. Kozak, and D. Kabat. 1990. Activation of erythropoietin receptors by Friend viral gp55 and by erythropoietin and downmodulation by the murine Fv-2r resistance gene. Proc. Natl. Acad. Sci. USA 87:9985-9989.
20. Ikuta, K., T. Kina, I. MacNeil, N. Uchida, B. Peault, Y. H. Chien, and I. L. Weissman. 1990. A developmental switch in thymic lymphocyte maturation potential occurs at the level of hematopoietic stem cells. Cell 62:863-874.
21. Ishihara, C., M. Miyazawa, J. Nishio, and B. Chesebro. 1991. Induction of protective immunity to Friend murine leukemia virus in genetic nonresponders to virus envelope protein. J. Immunol. 146:3958-3963.
22. Iwashiro, M., T. Kondo, T. Shimizu, H. Yamagishi, K. Takahashi, Y. Matsubayashi, T. Masuda, A. Otaka, N. Fujii, A. Ishimoto, M. Miyazawa, M. J. Robertson, B. Chesebro, and K. Kuribajashi. 1993. Multiplicity of virusencoded helper T-cell epitopes expressed on FBL-3 tumor cells. J. Virol. 67:4533-4542.
23. Johnson, P., and S. Benchimol. 1992. Friend virus-induced murine erythroleukaemia: the p53 locus. Cancer Surv. 12:137-151.
24. Johnson, P., S. Chung, and S. Benchimol. 1993. Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin. Mol. Cell. Biol. 13:1456-1463.
25. Rabat, D. 1989. Molecular biology of Friend viral erythroleukemia. Curr. Top. Microbiol. Immunol. 148:1-42.
26. Killeen, N., S. Sawada, and D. R. Littman. 1993. Regulated expression of human CD4 rescues helper T cell development in mice lacking expression of endogenous CD4. EMBO J. 12:1547-1553.
27. Kitagawa, M., O. Matsubara, and T. Kasnga. 1986. Dynamics of lymphocytic subpopulations in Friend leukemia virus-induced leukemia. Cancer Res. 46:3034-3039.
28. Kitamura, D., J. Roes, R. Kuhn, and K. Rajewsky. 1991. A B-cell-dencient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350:423-426.
29. Klein, J. 1975. Biology of the mouse histocompatibility complex. Springer-Verlag, New York, N. Y.
30. Lander, M. R., and S. K. Chattopadhyay. 1984. A Mus dunni cell line that lacks sequences closely related to endogenous murine leukemia viruses and can be infected by ecotropic, amphotropic, xenotropic, and mink cell forus-forming viruses. J. Virol. 52:695-698.
31. Lavigueur, A., and A. Bernstein. 1991. p53 transgenic mice: accelerated erythroleukemia induction by Friend virus. Oncogene 6:2197-2201.
32. Li, J.-P., A. D. D'Andrea, H. F. Lodish, and D. Baltimore. 1990. Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature (London) 343:762-764.
33. Lilly, F. 1968. The effect of histocompatibility-2 type on response to the Friend leukemia virus in mice. J. Exp. Med. 127:465-473.
34. Lilly, F. 1970. Fv-2: identification and location of a second gene governing the spleen focus response to Friend leukemia virus in mice. J. Natl. Cancer Inst. 45:163-169.
35. Locksley, R. M., S. L. Reiner, F. Hatam, D. R. Littman, and N. Killeen. 1993. Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice. Science 261:1448-1451.
36. f-mediated resistance to Friend virus-induced erythroleukemia. J. Virol. 66:3652-3660.
37. Miyazawa, M., R. Fujisawa, C. Ishihara, Y. A. Takei, T. Shimizu, H. Uenishi, H. Yamagishi, and K. Kuribayashi. 1995. Immunization with a single T helper cell epitope abrogates Friend virus-induced early erythroid proliferation and prevents late leukemia development. J. Immunol. 155:748-758.
38. Miyazawa, M., J. Nishio, K. Wehrly, C. S. David, and B. Chesebro. 1992. Spontaneous recovery from Friend retrovirus-induced leukemia. Mapping of the Rfv-2 gene in the Q/TL region of mouse MHC. J. Immunol. 148:1964-7.
39. Moreau-Gachelin, F., D. Ray, N. J. de Both, M. J. van der Feltz, P. Tambourin, and A, Tavitian. 1990. Spi-1 oncogene activation in Rauscher and Friend murine virus-induced acute erythroleukemias. Leukemia 4:20-23.
40. Moreau-Gachelin, F., D. Ray, M. G. Mattel, P. Tambourin, and A. Tavitian. 1989. The putative oncogene Spi-1: murine chromosomal localization and transcriptional activation in murine acute erythroleukemias. Oncogene 4:1449-1456. (Erratum, 5:941, 1990.)
41. Moreau-Gachelin, F., A. Tavitian, and P. Tambourin. 1988. Spi-1 is a putative oncogene in virally induced murine erythroleukemia. Nature (London) 331:277-280.
42. Morrison, R. P., P. L. Earl, J. Nishio, D. L. Lodmell, B. Moss, and B. Chesebro. 1987. Different H-2 subregions influence immunization against retrovirus and immunosuppression. Nature (London) 329:729-732.
43. Munroe, D. G., J. W. Peacock, and S. Benchimol. 1990. Inactivation of the cellular p53 gene is a common feature of Friend virus-induced erythroleukemia: relationship of inactivation to dominant transforming alleles. Mol. Cell. Biol. 10:3307-3313.
44. Paul, R., S. Schuetze, S. L. Kozak, C. A. Kozak, and D. Kabat 1991. The Sfpi-1 proviral integration site of Friend erythroleukemia encodes the etsrelated transcription factor Pu.1. J. Virol. 65:464-467.
45. Perry, L. L., M. Miyazawa, K. Hasenkrug, K. Wehrly, C. S. David, and B. Chesebro. 1994. Contrasting effects from a single major histocompatibility complex class II molecule (H-2E) in recovery from Friend virus leukemia. J. Virol. 68:4921-4926.
46. d major histocompatibility complex haplotype. Proc. Natl. Acad. Sci. USA 88:9243-9247.
47. Robertson, M. N., M. Miyazawa, S. Mori, B. Caughey, L. H. Evans, S. F. Hayes, and B. Chesebro. 1991. Production of monoclonal antibodies reactive with a denatured form of the Friend murine leukemia virus gp70 envelope protein: use in a focal infectivity assay, immunohistochemical studies, electron microscopy and Western blotting. J. Virol. Methods 34:255-271.
48. Schuetze, S., R. Paul, B. C. Gliniak, and D. Kabat 1992. Role of the PU.1 transcription factor in controlling differentiation of Friend erythroleukemia cells. Mol. Cell. Biol. 12:2967-2975.
49. Silver, J., and N. Teich. 1981. Expression of resistance to Friend virusstimulated erythropoiesis in bone marrow chimeras containing Fv-2rr and Fv-2ss bone marrow. J. Exp. Med. 154:126-137.
50. + T cells in the Friend murine retrovirus neutralizing antibody response: evidence for functional T cells in genetic low-recovery mice. J. Virol. 72:9400-9403.
51. Suzuki, S., and A. A. Axelrad. 1980. FV-2 locus controls the proportion of erythropoietic progenitor cells (BFU-E) synthesizing DNA in normal mice. Cell 19:225-236.
52. Tambourin, P., F. Wendung, and F. Moreau-Gachelin. 1981. Friend leukemia as a multiple-step disease. Blood Cells 7:133-144.
53. Van der Gaag, H. C., and A. A. Axelrad. 1990. Friend virus replication in normal and immunosuppressed C57BL/6 mice. Virology 177:837-839.
54. + cytolytic T cells. Nature (London) 344:742-746.